2 Beaten-Up Stocks for Bargain Hunters

NASDAQ: CSII | Cardiovascular Systems, Inc. News, Ratings, and Charts

CSII – Given rising uncertainties in the stock market, it could be wise to bet on beaten-down stocks that possess solid growth attributes. And we believe Cardiovascular Systems (CSII) and Itron (ITRI) meet those qualifications. They both look undervalued at their current price levels and have the potential to generate outsized returns. Read on.

The S&P 500 has climbed more than 20% this year, roughly double its long-term historical average. However, because we are now in what has historically been the stock market’s weakest month of the year, it could be wise for investors to shift some of their holding to stocks that have been beaten down but have the potential to rebound quickly.

The Federal Reserve’s conviction that inflation will subside, and an expected continuation of its accommodative monetary policy, should drive the performance of value stocks in the coming months.

Given this backdrop, we think Cardiovascular Systems, Inc. (CSII) and Itron Inc. (ITRI), which look undervalued at their current price levels, could be ideal bets now. These two stocks are well-positioned to rebound based on their strong fundamentals and solid growth attributes.

Cardiovascular Systems, Inc. (CSII)

CSII is a medical device company in St. Paul, Minn., develops and distributes solutions for peripheral and coronary artery diseases in the United States and internationally. It offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types and address various limitations related to surgical, catheter, pharmacological treatment alternatives, and peripheral support products. In addition, the company has collaborated with Chansu Vascular Technologies, LLC to create everolimus drug-coated peripheral and coronary balloons.

During its fourth fiscal quarter, ended June 30, 2021, CSII’s net revenue increased 66.9% year-over-year to $70.99 million. Its gross profit surged 55.4% from the prior-year quarter to $50.35 million. The company reported an adjusted EBITDA of $2,000, compared to a $10.56 million negative adjusted EBITDA in the fourth quarter of 2020.

An $0.04  consensus EPS estimate for the next year represents a 125% improvement year-over-year. The $299.67 million consensus revenue estimate for the current year represents a 15.7% increase from the same period last year. The stock has returned 4.9% over the past year to close yesterday’s trading session at $35.25. CSII is currently trading lower than its 50- and 200-day moving averages of $38.09 and $39.88, respectively.

In terms of forward Price/Sales, CSII is currently trading at 4.73x, which is 41.8% lower than the 8.13x industry average. Also, in terms of its forward EV/Sales, the stock is currently trading at 4.12x, which is 41.2% lower than the 7x industry average. 

CSII’s POWR Ratings reflect this promising outlook. The company has an overall B rating, which translates to Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

CSII is also rated a B grade for Value. Within the Medical – Devices Equipment industry, it is ranked #50 of 183 stocks.

To see additional POWR Ratings for Growth, Stability, Quality, Momentum, and Sentiment for CSII, click here.

Click here to checkout our Healthcare Sector Report for 2021

Itron Inc. (ITRI)

ITRI, a Liberty Lake, Wash.-based technology and service company, offers end-to-end solutions to help manage operations in the energy, water, and smart-city sectors worldwide. Device Solutions; Networked Solutions; and Outcomes are the company’s three operational segments. In addition, it offers services such as implementation, project management, installation, consulting, post-sale maintenance, cloud and software-as-a-service (SaaS) and extended or customer-specific warranties.

In July, ITRI integrated Grid4C’s Grid Edge AI application into its  expanding distributed intelligence (DI) applications ecosystem. Grid4C has successfully installed its Grid Edge AI app in Itron’s Raleigh DI Lab, and it will be available via the Itron Enterprise Application Center later this year. This collaboration should  provide new predictive insights to better balance supply and demand, offer new products and services, improve distributed energy resources, and boost consumer engagement.

During the second quarter, ended June 30, 2021, ITRI’s gross profit increased 8.2% year-over-year to $149.88 million. Its operating expenses declined 14.7% from its  year-ago value to $156.81 million. In addition, for the six months ended June 30, 2021, the company’s net cash from operating activities increased 375.8% year-over-year to $122.68 million.

ITRI is expected to generate 9.7%  revenue growth in the  current year. In addition, its EPS is estimated to increase 87.7% year-over-year to $2.44 in 2022. ITRI’s stock has gained 36.8% in price over the past year to close yesterday’s trading session at $78.88. However, ITRI is trading lower than its 50-day and 200-day moving averages of $87.72 and $92.58, respectively.

In terms of forward Price/Book, ITRI’s 2.96x is 53.9% lower than the 6.41x industry average. In addition, its 1.71x forward Price/Sales is 58.5% lower than the 4.12x industry average.

ITRI’s strong fundamentals are reflected in its POWR Ratings. The stock has an overall B rating, which equates to Buy in our POWR Ratings system. The stock also has an A grade for Momentum, and a B for Growth and Quality. In the B-rated Industrial -Services industry, it is ranked #24 of 88 stocks.

In total, we rate ITRI on eight different levels. Beyond what we’ve stated above, we have also given ITRI grades for Stability, Sentiment, and Value. Get all the ITRI ratings here.

Click here to check out our Industrial Sector Report for 2021


CSII shares were trading at $35.05 per share on Monday morning, down $0.20 (-0.57%). Year-to-date, CSII has declined -19.90%, versus a 20.09% rise in the benchmark S&P 500 index during the same period.


About the Author: Pragya Pandey


Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CSIIGet RatingGet RatingGet Rating
ITRIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2022 Stock Market Outlook

The stock market (SPY) has continued on a bullish path in 2021. Will that continue in 2022? And what could happen to awaken the bear market from hibernation? 40 year investment veteran Steve Reitmeister explores this and more in this early edition of his 2022 Stock Market Outlook. Read on for full details below...

:  |  News, Ratings, and Charts

How Recent Bearish Sentiment Will Impact the Stock Market

Last week, the S&P 500 (SPY) fell during a short trading week. Multiple factors were weighing on investor sentiment. First was September's history for being a weaker month for stock performance. In addition, the previous week's August payrolls miss seemed to linger on investors' minds due to concerns that the delta variant of COVID was slowing the rebound in the economy. The real estate sector led declines as long-term interest rates increased. Consumer staples and utility stocks performed the best. In terms of market cap, the small-cap Russell 2000 Index underperformed the market after two strong weeks of outperforming the larger benchmarks. Growth stocks also outperformed Value stocks. I’ll discuss this and more below…

:  |  News, Ratings, and Charts

How to Turn Low Priced Stocks into BIG Winners?

Some investors are into growth stocks...some prefer value stocks while others are into momentum, income, chart patterns, insider trading and more. But one area that most investors agree upon is the great appeal in buying low priced stocks. Like those under $10 given the potential that prices soar and you easily beat the stock market (SPY). Read on to discover our brand new strategy for selecting low priced stocks that has led to a surprising +62.88% average annual return. Get the rest below...

:  |  News, Ratings, and Charts

3 Growth Stocks You Can Buy at a Reasonable Price

Even with growth stocks falling last week, investors are still pouring money into companies with strong growth potential. When you add in a value component, you get the best of both worlds. That's why investors should consider growth at a reasonable price stocks such as Westlake Chemical Corporation (WLK), ManpowerGroup (MAN), AutoNation, Inc. (AN).

:  |  News, Ratings, and Charts

How to Turn Low Priced Stocks into BIG Winners?

Some investors are into growth stocks...some prefer value stocks while others are into momentum, income, chart patterns, insider trading and more. But one area that most investors agree upon is the great appeal in buying low priced stocks. Like those under $10 given the potential that prices soar and you easily beat the stock market (SPY). Read on to discover our brand new strategy for selecting low priced stocks that has led to a surprising +62.88% average annual return. Get the rest below...

Read More Stories

More Cardiovascular Systems, Inc. (CSII) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CSII News